数字化医疗:本地挑战、全球机遇(英文版)

November 2015 Independent Technology Research Report DIGITAL HEALTHCARE Important disclosures appear at the back of this report GP Bullhound LLP is authorised and regulated by the Financial Conduct Authority Local Challenges, Global Opportunities Digital technology is coming of age in the healthcare sector Governments, insurers, employers and most importantly patients and their physicians recognise that digital technology is the key to meeting the challenges of healthcare provision in the 21st Century. The most relevant and exciting digital services and applications are being developed by fast growing SMEs. Healthcare systems worldwide are facing unprecedented challenges Global healthcare spend accounts for 10.6% of GDP. Spend is forecast to grow more than 5% annually to 2018 as the global proportion of those aged over 60 increases from 12% in 2013 to 21% in 2050. The nature of the challenges faced varies across national markets, but the impetus for new models of healthcare is clear globally. Digital enables transformational models of admin, funding and care Cloud software, smartphone applications, online marketplaces and data analytics are established technologies that the healthcare sector is only now embracing. They are key as healthcare seeks to become more efficient and patient centric, paying for outcomes delivered and with much care and treatment provided remotely. B2B models are best placed – but sales strategies must be multifaceted Digital healthcare companies selling to, or partnering with, enterprise level clients will be the winners in the medium term. SMEs must sell in at the board and departmental, national and local level to maximise their chances of success. SMEs must be healthcare experts as well as digital natives Healthcare is incredibly complex – from heavy regulation to labyrinthine decision making to multi-layered payment systems. The most successful in the space will be those who embrace the complexity and thrive on it. Investment is gaining momentum - Q3 2015 was a record quarter $1.5bn was raised by digital healthcare companies in Q3 2015. US companies continue to account for the majority of funds raised in the sector, but there is also a vibrant earlier stage community of European digital healthcare companies. M&A volumes are increasing steadily, driven by interest from a wide variety of strategics. CHRIS GRAVES chris.graves@gpbullhound.com UK: +44 207 101 7577 HARRIET ROSETHORN harriet.rosethorn@gpbullhound.com UK: +44 207 101 7591 Digital Healthcare – Local Challenges, Global Opportunities Page 4 of 44 Table of Contents Introduction – The Global Healthcare Market .......................................................................... 5 Digital Healthcare and the Trends Shaping it ........................................................................... 7 The rise of the smartphone ...............................................................

立即下载
医药生物
2018-07-31
GP.Bullhound
44页
1.73M
收藏
分享

[GP.Bullhound]:数字化医疗:本地挑战、全球机遇(英文版),点击即可下载。报告格式为PDF,大小1.73M,页数44页,欢迎下载。

本报告共44页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共44页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
医药行业 2018 年中期投资策略
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
上市药企归母净利润规模(亿元) 图表 39:上市药企归母净利润增速(%)
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
医药各细分行业的市盈率水平 图表 35:医药各细分行业的市净率水平
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
医药行业和 A 股市盈率溢价比率变化图谱 图表 33:医药行业和 A 股市净率溢价比率变化图谱
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
各个行业预测市盈率对比 图表 31:各个行业市净率对比
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
沪股通持股比例前十医药股表现情况 图表 29:深股通持股比例前十医药股表现情况
医药生物
2018-07-31
来源:医药行业2018年中期投资策略报告:增长稳健,创新前行
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起